Home|Journals|Articles by Year|Audio Abstracts
 

Research Article



Experimental study on potential protective effect of camel milk on cholesterol-induced fatty liver disease of Albino Rats

Ayman Balla Mustafa,Abdalla Ramadan Elgenaidi,Emhemed Abukhattala.




Abstract
Cited by 0 Articles

Background: Fatty liver disease is considered to be the most common cause of persistently elevated liver enzymes in the general population and is significantly associated with higher body mass index and metabolic syndrome. Aim: The study was designed to investigate the therapeutic effect of camel milk on fatty diet-induced dyslipidemia and liver dysfunction in albino rats. Methods: 32 Wister Albino rats of both sexes with an average weight of 151.16±11.68 gm were divided into 4 groups. Group I (control group): The rats received standard ration. Group II: rats received a high-fat diet (HFD). Group III: free access to fresh milk plus a standard ration and group IV: rats were free access to fresh milk plus high fat diet. By end of experiment, 32 blood samples were collected and delivered promptly to the laboratory for biochemical examination. Numerical data were analyzed to determine the difference between means. Results: The result revealed that the mean of FBG, blood lipid, and liver enzymes were significantly different (P

Key words: Albino Rats, Camel Milk, High Fat Diet, Liver disease, Therapeutic Effect.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.